Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zevra Therapeutics (ZVRA) Change in Cash (2018 - 2025)

Zevra Therapeutics' Change in Cash history spans 11 years, with the latest figure at $8.0 million for Q4 2025.

  • For Q4 2025, Change in Cash rose 139.34% year-over-year to $8.0 million; the TTM value through Dec 2025 reached $28.6 million, up 408.95%, while the annual FY2025 figure was $28.6 million, 408.95% up from the prior year.
  • Change in Cash reached $8.0 million in Q4 2025 per ZVRA's latest filing, up from $6.7 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $71.7 million in Q1 2021 to a low of -$25.3 million in Q1 2023.
  • Average Change in Cash over 5 years is $2.9 million, with a median of -$506000.0 recorded in 2021.
  • Peak YoY movement for Change in Cash: surged 7178.38% in 2021, then tumbled 9106.36% in 2024.
  • A 5-year view of Change in Cash shows it stood at -$19.2 million in 2021, then surged by 75.67% to -$4.7 million in 2022, then soared by 95.28% to -$220000.0 in 2023, then crashed by 9106.36% to -$20.3 million in 2024, then skyrocketed by 139.34% to $8.0 million in 2025.
  • Per Business Quant, the three most recent readings for ZVRA's Change in Cash are $8.0 million (Q4 2025), $6.7 million (Q3 2025), and $10.4 million (Q2 2025).